Business Wire

Miro Acquires Reforge to Help Organizations Navigate the Transition to AI

24.3.2026 14:00:00 CET | Business Wire | Press release

Share

Together, Reforge and Miro will provide a powerful and highly differentiated solution for teams that blends the tools and knowledge needed to innovate in the AI era

Miro®, the AI Innovation Workspace for teams, today announced that it has acquired (subject to customary closing conditions) Reforge, an AI platform for product teams. The deal includes Reforge's team, learning platform, and AI-powered product development tools.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260324623461/en/

Organizations are grappling with how to leverage AI to its full potential. In many cases, the problem is not how to code faster, but deciding what to build. That's the bottleneck slowing companies down today. Miro and Reforge are both solving this challenge for customers – tackling the need to build both at speed and with clear strategic direction. Miro brings a collaborative AI workflows platform that brings teams and AI together to plan, co-create, and build at scale. Reforge brings AI-first product development tools, rigorous frameworks, and expert training that teach teams how to make good decisions and build the right thing. Combining Miro’s AI Innovation Workspace with Reforge's knowledge and products creates a comprehensive solution for product teams navigating AI transformation: the platform to accelerate their work and the expertise to direct it.

“The biggest opportunity ahead isn't just moving faster – it's moving faster in the right direction,” said Andrey Khusid, CEO and Founder at Miro. “Teams need support in accelerating what to build and the decision-making during that critical phase of work. Reforge has been instrumental in helping teams learn from the best in the industry and sharpen their product and growth skills. The combination of Miro and Reforge will help organizations to transform towards AI-enabled innovation faster.”

The product development lifecycle is undergoing its largest transformation since inception. Reforge has spent years taking best practices from industry leaders and turning them into repeatable, rigorous frameworks. They teach operators how to solve the hardest problems – a skillset that's more critical than ever. Beyond training, Reforge has built a growing technology business with AI-first solutions that address key gaps in the product development process, creating deep connections with customers, including large enterprises.

“A couple of years ago, we saw that AI was changing not just the tools product teams use, but the skills and judgment they need to succeed,” said Brian Balfour, Founder and CEO at Reforge. “Teams that once relied on intuition and experience now need fluency in AI prototyping, evals, and strategy. We built Reforge to close that gap. Joining Miro lets us do it faster and at a much bigger scale than we could reach on our own.”

Balfour continues, “What started as a single course has grown into a community of over 100,000 alumni and a suite of products used by product teams everywhere. That growth reflects how much the work of building products has changed. Teams need new frameworks, new skills, and better tools to keep up. Joining Miro gives our community and our products the scale to help far more of them do that.”

Key elements of the acquisition:

  • Reforge Learning will continue to operate as a separate entity at Reforge.com. Investment in new courses will continue, and the Reforge learning platform will maintain independent, vendor-neutral courseware.
  • Brian Balfour, Reforge’s current CEO, will join Miro as the company’s new Chief Growth Officer.
  • Tom Willerer, Reforge’s current COO, will join Miro as the company’s Chief Strategy Officer.
  • Reforge has more than 100,000 Reforge Learning alumni, and its customers include: Workday, Xero, SAP, Mastercard, and Netflix.

This acquisition accelerates Miro as a critical platform for teams building products in the AI era. Together, Miro and Reforge deliver what modern organizations need: the collaborative AI platform where teams make better decisions, combined with the frameworks and training to navigate the biggest transformation in product development history. The result is a fundamental shift in how companies innovate and build for the future.

About Miro

Miro is the AI Innovation Workspace that brings teams and AI together to plan, co-create, and build the next big thing, faster. Serving more than 100 million users across 250,000 customers, Miro empowers cross-functional teams to flow from early discovery through final delivery on a shared, AI-first canvas. With the canvas as the prompt, Miro's collaborative AI Workflows keeps teams in the flow of work, scales shifts in ways of working, and drives organization-wide transformation. Founded in 2011, Miro currently employs more than 1,600 people in 14 hubs around the world. To learn more, visit https://miro.com.

Miro and the Miro logo are trademarks or registered trademarks of RealtimeBoard, Inc., in the United States and/or other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.

About Reforge

Reforge is the operating platform for product teams, combining the largest professional community of experienced product, growth, and marketing operators with a suite of AI-native tools purpose-built for product discovery. Reforge Insights aggregates and synthesizes customer feedback to surface what matters most, Reforge Research powers AI-driven surveys and interviews at scale, and Reforge Build enables rapid prototyping to test ideas before committing engineering resources. Backed by a network of over 100,000 alumni from the world's top technology companies, Reforge helps teams close the growing gap between the speed of modern engineering execution and the pace of product discovery. Learn more at https://reforge.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260324623461/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye